RISK FACTORS AND COMPLICATIONS OF OSTEOARTICULAR INFECTIONS

Abstract

Infection is one of the most feared complications in traumatology and orthopedic surgery, which requires treatment by a multidisciplinary team. The purpose of this research was to identify the risk factors and complications of osteoarticular infections of a hospital in Guayaquil. The present study is of a descriptive, observational, retrospective and cross-sectional type that analyzed 103 patients of the external Traumatology and Orthopedics office of the Teodoro Maldonado Carbo specialty hospital during the period from January 1, 2015 to December 31, 2016 The most affected gender was the male, predominated with 94% of the total, 45% was in the age group of 15-25 years of age and the average age was 40.38 years (Range: 15-97 years ). The risk factors were present in 75% of the patients, the main ones were systemic disease with 46% and sobadura in 19%. Diabetes mellitus (67%) represented the main systemic disease associated with osteoarticular infections. The clinical complication rate was 25%, of which 35% corresponded to arthrofibrosis, followed in 23% of sepsis. There were 21% of sequels. The risk of clinical complications is directly proportional to the age group, risk factors, and history of revision arthroplasty.

Keywords: Risk factors, osteoarticular infection, complications.

References

[1]R. V. Thakore, S. E. Greenberg and H. Shi, "Surgical site infection in orthopedic trauma: a case-control study evaluating risk factors and cost", J Clin Orthop Trauma, Vol. 6, no. 2, pp.220–226. 2015.

[2]S. Tschudin-Sutter, R. Frei and M. Dangel, "Validation of a treatment algorithm for orthopaedic implant-related infections with device-retention-results from a prospective observational cohort study", Clin Microbiol Infect, Vol. 22, no.3, pp. 457.e1-457.e9.

[3]A. Maleb, F. M. Frikh and B. Lahlou, "Bacteriological aspects of chronic osteoarticular infections in adults: the influence of the osteosynthesis material", BMC Res Notes, Vol. 10, no. 3, pp. 635-8, Nov 2017.

[4]M. Titécat, E. Senneville, F. Wallet and H. Dezèque, “Bacterial epidemiology of osteoarticular infections in a referent center: 10-year study”, Orthop Traumatol Surg Res. Vol. 99, no. 6, pp. 653-8. Oct, 2015.

[5]T. N. Peel et al, “Outcome of debridement and retention in prosthetic joint infections by methicillin-resistant staphylococci, with special reference to rifampin and fusidic acid combination therapy. Antimicrob”. Agents Chemother. Vol. 57, no. 1, pp. 350–355. 2014.

[6]Z. B. Tani and G. Arlet, “Actualité de la résistance aux antibiotiques chez les bacilles à Gram négatif en Algérie”, Pathol Biol (Paris), Vol. 62, no. 3, pp. 169–178.

[7]L. Morata and A. Soriano, “The role of fosfomycin in osteoarticular infection”, Rev Esp Quimioter. Vol. 32, no. 1, pp. 30–36. May, 2019.

[8]N. Benito, M. Franco, A. Ribera et al, “Time trends in the aetiology of prosthetic joint infections: a multicentre cohort study” Clin Microbiol Infect. Vol. 22, no. 8, pp. 732.e1-8, 2016.

[9]A. J. Moore, A. W. Blom, M. R. Whitehouse and R. Gooberman-Hill, “Deep prosthetic joint infection: a qualitative study of the impact on patients and their experiences of revision surgery”, BMJ Open. Vol. 5, no. 12, pp. e009495, 2015.

[10]E. Tornero, L. Morata and J. C. Martínez-Pastor, “Importance of selection and duration of antibiotic regimen in prosthetic joint infections treated with debridement and implant retention”, J Antimicrob Chemother, Vol. 71, no.1, pp. 1395e401, 2016.